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vBackground
Y
oung adults aged 18–24 currently have a higher smoking prevalence and lower 
quit rate than older adults.2 This cohort is a critical age group given heightened 
tobacco industry advertising targeted to young adults following the 1998 law 
prohibiting the marketing of tobacco products to adolescents under 18 years of age. 
Effective treatment for tobacco dependence among young adults provides a vital 
means to help future generations of American adults avert lifelong tobacco use and 
dependence, as well as tobacco-caused disease and premature death.
Few smoking cessation studies report results by age. In one of the first studies of its 
kind, Susan Curry and her research team including Amy Sporer, Oksana Pugach, 
Richard Campbell and Sherry Emery of the Institute for Health Research and Policy at 
the University of Illinois at Chicago analyzed 2005 National Health Interview Survey 
(NHIS) data to examine differences in smoking cessation treatment use among young 
and older adult smokers. NHIS is an annual multipurpose health survey that uses 
a multistage sample designed to represent the civilian non-institutionalized popula-
tion of the United States.2 The 2005 NHIS surveyed 31,428 adults aged 18 and older. 
Among respondents, current smokers (N=6,511) were analyzed for this research.
Key Findings
The prevalence of current smoking among adults in the analytic study sample aged  ■
18 to 24 was 24 percent, while that for adults older than 24 years was 20 percent.
Compared to older adult smokers, significantly fewer young adult smokers  ■
reported having insurance coverage (76% versus 59%, respectively).
Younger adults were significantly more likely than older adults to report a serious  ■
attempt to quit in the past year (49% versus 42%, respectively). Motivation to quit 
smoking was similar across both age groups, with about 70 percent reporting that 
they wanted to completely quit smoking.
Fewer young adult smokers reported receiving or using a formal tobacco cessation  ■
treatment. Young adult smokers were less likely than older adults to have visited 
a doctor or dentist in the past 12 months (74% versus 81%, respectively), to have 
been asked about smoking by a health professional (58% versus 67%), to have 
their physician know about their smoking (27% versus 45%) and to have been 
advised to quit smoking by a health professional (49% versus 60%).
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POLICY PERSPECTIVE
THougH moRe YouNg 
AdulTS THAN oldeR AdulTS 
RepoRTed TRYiNg To quiT 
SmokiNg iN 2005,1 FeWeR 
YouNg THAN oldeR AdulTS 
uTilized evideNCe-bASed 
TobACCo CeSSATioN 
TReATmeNTS. eFFoRTS To 
iNCReASe THe AppeAl, uSe 
ANd eFFiCACY oF pRoveN 
CeSSATioN TReATmeNTS 
AmoNg YouNg AdulTS 
Hold gReAT pRomiSe To 
Help ReduCe SmokiNg 
RATeS iN FuTuRe u.S. AdulT 
geNeRATioNS. impRoved 
ASSeSSmeNT oF TReATmeNT 
uSe ANd pReFeReNCeS iS 
CRiTiCAl FoR moNiToRiNg 
THe NATioN’S pRogReSS 
ToWARd gReATeR TobACCo 
CeSSATioN TReATmeNT 
uSe bY YouNg AdulT 
SmokeRS ANd FoR 
evAluATiNg THe impACT oF 
TobACCo CeSSATioN mediA 
CAmpAigNS Aimed AT YouNg 
AdulTS.  1 Results from the 2005 National Survey on Drug Use and Health: National Findings. Rockville, MD: Substance Abuse and 
Mental Health Services Administration, 2006. http://www.oas.samhsa.gov/nsduh/2k5nsduh/2k5Results.pdf
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Support from friends and family was the most commonly reported form of  ■
tobacco cessation assistance among younger and older smokers (34% versus 
27%, respectively). Use of FDA-approved pharmacotherapies (i.e., nicotine gum, 
nicotine patch, other nicotine replacement products and/or bupropion [Zyban or 
Welbutrin]) surpassed use of evidence-based behavioral treatment methods (i.e., 
counseling provided through telephone quit lines, stop smoking clinics, classes or 
groups, or one-on-one counseling) (18% versus 4%, respectively, among smokers 
aged 18 to 24 and 33% versus 5%, respectively, among smokers aged 25 and older).
There were no differences between age groups regarding those who reported  ■
utilizing any behavioral treatment and those who utilized both behavioral and 
pharmacotherapy treatments combined.
Correlates of Pharmacotherapy Use Among Current Smokers Who Made a Serious Quit Attempt 
in the Past Year: National Health Interview Survey, 2005
 Young Adults, Adults
 Aged 18–24 y Aged ≥ 25 y
 (n = 387) (n = 2360)
 OR (95% CI) OR (95% CI)
Woman vs man 0.82 (0.45, 1.50) 1.39 (1.10, 1.76)
White vs othera 0.43 (0.21, 0.87) 1.62 (1.26, 2.07)
High-school graduate vs non-high school graduateb 4.70 (1.55, 14.24) 0.83 (0.59, 1.16)
Some college vs non-high school graduateb 4.87 (1.61, 14.74) 1.04 (0.77, 1.42)
College graduate vs non-high school graduateb 5.57 (1.09, 28.57) 1.50 (0.98, 2.30)
Health insurance vs none 1.57 (0.78, 3.16) 1.50 (1.10, 2.06)
Health care visit vs none 1.02 (0.33, 3.20) 1.02 (0.68, 1.53)
Advised to quit by health care professional vs none 3.14 (1.50, 6.54) 1.88 (1.45, 2.42)
10 cigarettes per day differencec 2.00 (1.22, 3.27) 1.46 (1.28, 1.66)
Note. OR = odds ratio; Cl = confidence interval.
aSignificance of interaction term testing for differences in odds ratios between age groups; P < .001.
bSignficance of interaction term testing for differences in odds ratios between age groups; P < .01.
cAmount smoked was entered as a continuous variable in the regression model. OR and 95% CI were calculated to compare a referent 
smoker to one who smoked 10 cigarettes less per day.
Among the correlates of treatment use in young adult smokers aged 18–24 years: 
Non-whites (i.e., non-Hispanic African Americans, Hispanics, Asian/Pacific  ■
Islanders and other races) were more likely than were whites to use pharmaco -
therapy (odds ratio= 0.43; 95% confidence interval (0.21, 0.87)). 
Smokers that obtained higher education levels were more likely than those with  ■
less education to use pharmacotherapy. Compared to non-high school graduates, 
high school graduates were nearly five times more likely to use pharmacotherapy 
(odds ratio= 4.70; 95% confidence interval (1.55, 14.24)); those who attended 
some college were 4.87 times more likely to use pharmacotherapy (odds ratio= 
4.87; 95% confidence interval (1.61, 14.74)); and college graduates were almost 
six times more likely to use pharmacotherapy (odds ratio= 5.57; 95% confidence 
interval (1.09, 28.57)).
Those who were advised by a health care professional to quit smoking were  ■
3.14 times more likely than were those who received no quitting  advice from a 
health care professional to use pharmacotherapy; 95 percent confidence interval 
(1.50, 6.54).
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Heavier smokers were twice as likely as lighter smokers (who smoke 10 cigarettes  ■
less per day) to use pharmacotherapy (odds ratio = 2.0; 95% confidence interval 
(1.22, 3.27)).
Young adult smokers are a critical target for tobacco cessation treatment. This study 
shows that evidence-based tobacco cessation treatments are underused by young adult 
smokers. Past research shows that the highest quit success rates are among young adults 
who utilized a combined treatment of telephone counseling and pharmacotherapy. 
This study supports the need for evidence-based cessation treatments among young 
adult smokers.
 
For more information on quitting smoking, call 1-800-QUITNOW or visit 
www.quitnow.gov.
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